Evidence map›Paper›PMID 37440066›Full record

ArticleAdvances in experimental medicine and biology2023

Environmental Light Has an Essential Effect on the Disease Expression in a Dominant RPE65 Mutation.

Wenjing Wu, Yusuke Takahashi, Xiang Ma, Gennadiy Moiseyev, Jian-Xing Ma

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wenjing WuDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Yusuke TakahashiDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Xiang MaDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Gennadiy MoiseyevDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Gennadiy-Moiseyev@ouhsc.edu.
Jian-Xing MaDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Jian-xing-ma@ouhsc.edu.
University of Oklahoma Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The retina pigmented epithelium 65 kDa protein (RPE65) is an essential enzyme in the visual cycle that regenerates the 11-cis-retinal chromophore obligatory for vision. Mutations in RPE65 are associated with blinding diseases. D477G (C.1430G > A) is the only known RPE65 variant to cause autosomal dominant retinitis pigmentosa (adRP). Previously, we reported that the heterozygous D477G knock-in (WT/KI) mice exposed to dim light intensity demonstrated delayed chromophore regeneration rates and slowed recovery of photoreceptor sensitivity following photobleaching. However, visual function and retinal architecture were indistinguishable from the wild-type (WT) mice. In this study, when maintained under the physiological day-light intensity (2 K lux), the WT/KI heterozygous mice displayed retina degeneration and reduced electroretinography (ERG) amplitude, recapitulating that observed in human patients. Our findings indicated the importance of the light environment in the mechanism of RPE65 D477G pathogenicity.

Indexed as

cis-trans-IsomerasesRetinal DegenerationAnimalsDisease Models, AnimalElectroretinographyEpitheliumEye ProteinsHumansMiceMutationRetinacis-trans-IsomerasesEye ProteinsBlindnessD477GInherited retinopathyLuminanceRetinitis pigmentosaRPE65Visual cycle

Identifiers

PMID37440066
OpenAlexW4384120555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.